Farrag, K.; Aksan, A.; Korotkova, M.; Idborg, H.; Jakobsson, P.-J.; Weigert, A.; Vieth, M.; Zeuzem, S.; Blumenstein, I.; Stein, J.
Interferon Regulator Factor 5: A Novel Inflammatory Marker and Promising Therapeutic Target in Ulcerative Colitis. Biomedicines 2025, 13, 2251.
https://doi.org/10.3390/biomedicines13092251
AMA Style
Farrag K, Aksan A, Korotkova M, Idborg H, Jakobsson P-J, Weigert A, Vieth M, Zeuzem S, Blumenstein I, Stein J.
Interferon Regulator Factor 5: A Novel Inflammatory Marker and Promising Therapeutic Target in Ulcerative Colitis. Biomedicines. 2025; 13(9):2251.
https://doi.org/10.3390/biomedicines13092251
Chicago/Turabian Style
Farrag, Karima, Aysegül Aksan, Marina Korotkova, Helena Idborg, Per-Johan Jakobsson, Andreas Weigert, Michael Vieth, Stefan Zeuzem, Irina Blumenstein, and Jürgen Stein.
2025. "Interferon Regulator Factor 5: A Novel Inflammatory Marker and Promising Therapeutic Target in Ulcerative Colitis" Biomedicines 13, no. 9: 2251.
https://doi.org/10.3390/biomedicines13092251
APA Style
Farrag, K., Aksan, A., Korotkova, M., Idborg, H., Jakobsson, P.-J., Weigert, A., Vieth, M., Zeuzem, S., Blumenstein, I., & Stein, J.
(2025). Interferon Regulator Factor 5: A Novel Inflammatory Marker and Promising Therapeutic Target in Ulcerative Colitis. Biomedicines, 13(9), 2251.
https://doi.org/10.3390/biomedicines13092251